Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis

NCT01156025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Adenoviral Keratoconjunctivitis

Interventions

DRUG: GV550
DRUG: placebo

Sponsor

Laboratoires Thea